Biomarkers in cardiovascular diseases

Biomarkers in cardiovascular diseases / editors, Dimitris Tousoulis, Christodoulos Stefanadis.

"The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pat...

Full description

Saved in:
Bibliographic Details
:
ProQuest (Firm)
TeilnehmendeR:
Tousoulis, Dimitris.
Stefanadis, Christodoulos.
ProQuest (Firm)
Year of Publication:2014
Language:English
Online Access:
Physical Description:viii, 439 p. :; ill.
Tags: Add Tag
No Tags, Be the first to tag this record!
id 5001335842
ctrlnum (MiAaPQ)5001335842
(Au-PeEL)EBL1335842
(CaPaEBR)ebr10735260
(CaONFJC)MIL518693
(OCoLC)855504706
collection bib_alma
record_format marc
spelling Biomarkers in cardiovascular diseases [electronic resource] / editors, Dimitris Tousoulis, Christodoulos Stefanadis.
Boca Raton : CRC Press, 2014.
viii, 439 p. : ill.
Includes bibliographical references and index.
pt. 1. Classical biomarkers -- pt. 2. Novel biomarkers.
"The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book"--Provided by publisher.
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
Cardiovascular system Diseases Diagnosis.
Cardiovascular system Diseases Prevention.
Electronic books.
Tousoulis, Dimitris.
Stefanadis, Christodoulos.
ProQuest (Firm)
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1335842 Click to View
language English
format Electronic
eBook
author2 Tousoulis, Dimitris.
Stefanadis, Christodoulos.
ProQuest (Firm)
author_facet Tousoulis, Dimitris.
Stefanadis, Christodoulos.
ProQuest (Firm)
ProQuest (Firm)
author2_variant d t dt
c s cs
author2_role TeilnehmendeR
TeilnehmendeR
TeilnehmendeR
author_corporate ProQuest (Firm)
author_sort Tousoulis, Dimitris.
title Biomarkers in cardiovascular diseases
spellingShingle Biomarkers in cardiovascular diseases
pt. 1. Classical biomarkers -- pt. 2. Novel biomarkers.
title_full Biomarkers in cardiovascular diseases [electronic resource] / editors, Dimitris Tousoulis, Christodoulos Stefanadis.
title_fullStr Biomarkers in cardiovascular diseases [electronic resource] / editors, Dimitris Tousoulis, Christodoulos Stefanadis.
title_full_unstemmed Biomarkers in cardiovascular diseases [electronic resource] / editors, Dimitris Tousoulis, Christodoulos Stefanadis.
title_auth Biomarkers in cardiovascular diseases
title_new Biomarkers in cardiovascular diseases
title_sort biomarkers in cardiovascular diseases
publisher CRC Press,
publishDate 2014
physical viii, 439 p. : ill.
contents pt. 1. Classical biomarkers -- pt. 2. Novel biomarkers.
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC670
callnumber-sort RC 3670 B56 42014
genre Electronic books.
genre_facet Electronic books.
url https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1335842
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.1/075
dewey-sort 3616.1 275
dewey-raw 616.1/075
dewey-search 616.1/075
oclc_num 855504706
work_keys_str_mv AT tousoulisdimitris biomarkersincardiovasculardiseases
AT stefanadischristodoulos biomarkersincardiovasculardiseases
AT proquestfirm biomarkersincardiovasculardiseases
status_str n
ids_txt_mv (MiAaPQ)5001335842
(Au-PeEL)EBL1335842
(CaPaEBR)ebr10735260
(CaONFJC)MIL518693
(OCoLC)855504706
is_hierarchy_title Biomarkers in cardiovascular diseases
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1792330754809659392
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02620nam a2200397 a 4500</leader><controlfield tag="001">5001335842</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">130314s2014 flua sb 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2013010316</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781466587144 (hardback : alk. paper)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781466587151 (e-book)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)5001335842</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL1335842</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10735260</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaONFJC)MIL518693</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)855504706</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC670</subfield><subfield code="b">.B56 2014</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.1/075</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Biomarkers in cardiovascular diseases</subfield><subfield code="h">[electronic resource] /</subfield><subfield code="c">editors, Dimitris Tousoulis, Christodoulos Stefanadis.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Boca Raton :</subfield><subfield code="b">CRC Press,</subfield><subfield code="c">2014.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 439 p. :</subfield><subfield code="b">ill.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">pt. 1. Classical biomarkers -- pt. 2. Novel biomarkers.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratification, in CVD diagnosis, or in monitoring therapy; many others may be risk factors themselves, representing therefore potential targets of therapy. The ideal biomarker should have the following characteristics: highly sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily interpretable by clinicians. The present book focuses on the presentation and evaluation of the most promising classical and novel biochemical markers used in CVD (coronary artery disease, hypertension, heart failure, hyperlipidemia, peripheral arterial disease). The underlying pathophysiological characteristics of each biomarker, as well as potential clinical implications in daily practice are reviewed in this book"--Provided by publisher.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiovascular system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Diagnosis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiovascular system</subfield><subfield code="x">Diseases</subfield><subfield code="x">Prevention.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tousoulis, Dimitris.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stefanadis, Christodoulos.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=1335842</subfield><subfield code="z">Click to View</subfield></datafield></record></collection>

Similar Items